Squawk on the Street podkast

Cramer's Morning Take: Microsoft & Viking Therapeutics 3/26/24

0:00
3:37
Do tyłu o 15 sekund
Do przodu o 15 sekund

Jim and Jeff discuss the analyst price target increase for Microsoft. They also talk about the weight loss drug opportunity for Viking Therapeutics. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake  

CNBC Investing Club Disclaimer

Więcej odcinków z kanału "Squawk on the Street"